More than 40 states have sped up vaccination programs, the latest being Kentucky and Washington.
Tag: Disease Rates
Virus Variants Can Infect Mice, Scientists Report
Infected rodents pose no immediate danger to humans, but the research suggests that mutations are helping the coronavirus expand its range of potential hosts.
The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents
A clinical trial found no symptomatic infections among vaccinated children ages 12 to 15, the companies said, and there were no serious side effects. The data have not yet been reviewed by independent experts.
A New Coronavirus Wave Hits Chile, Despite Vaccine Success
Experts say Chile’s government eased restrictions on travel, business and schools much too early, creating a false sense of confidence that the worst of the pandemic was over.
Biden Urges States to Restore Mask Mandates
“I am asking you to just hold on a little longer, to get vaccinated when you can, so that all of those people that we all love will still be here when this pandemic ends,” the C.D.C. director, Dr. Rochelle Walensky said.
Hawaii Residents Worry About Returning Tourists Heedless of Pandemic
For much of the pandemic, Hawaii had some of the strictest rules for visitors in the United States. But now testing can replace a quarantine in most areas.
Six States Open Vaccines to All Adults on Monday
“We must get every dose of vaccine into arms quickly,” said Gov. Laura Kelly of Kansas.
A Collapse Foretold: How Brazil’s Covid-19 Outbreak Overwhelmed Hospitals
The virus has killed more than 300,000 people in Brazil, its spread aided by a highly contagious variant, political infighting and distrust of science.
Pfizer Begins Testing Its Vaccine in Young Children
Other drug makers have begun similar trials of their Covid-19 vaccines. If they work in children younger than 12 as expected, it will be easier for the U.S. to reach herd immunity.
Why It Pays to Think Outside the Box on Coronavirus Tests
Universities and other institutions looking to protect themselves from Covid-19 may benefit from sharing their testing resources with the wider community, a new study suggests.